Cite
APA Citation
DeBoer, R., Koval, G., Mulkey, F., Wetzler, M., Devine, S., Marcucci, G., Stone, R. M., Larson, R. A., Bloomfield, C. D., Geyer, S., Mullighan, C. G., & Stock, W. (n.d.). clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leukemia & lymphoma, 57(10), 2298–2306. http://access.bl.uk/ark:/81055/vdc_100034959453.0x000035